Revisiting bacteriology diagnostics: how to make them globally available and accessible
April 23, 2025
|
Bacteriology
Read the latest publication by Liselotte Hardy
Antimicrobial resistance (AMR) poses a growing global threat, associated with 4.71 million deaths yearly. If we don’t take action to reduce this, the current trend will continue towards a sobering 8.22 million associated deaths in 2050. In light of this global emergency, we need to reevaluate the bacteriology diagnostics landscape, emphasizing global availability and accessibility. Resistant bacterial infections have the highest death toll in sub-Saharan Africa and are frequently inappropriately treated . This is fuelled by a lack of accessible diagnostics that was recently exposed by the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) study: as little as 1% of the laboratories from 14 surveyed sub-Saharan countries performed bacterial diagnostics, and only 86% of these had access to reliable antibiotic susceptibility testing (AST).
Against this reality, the World Health Organization (WHO) essential diagnostics list (EDL) recommends that AST should be available in at least 50% of clinical laboratories, or accessible to at least 80% of the population. This target is ambitious, yet feasible if international efforts are taken to scale up clinical bacteriology testing facilities in resource-limited settings (RLS), adapted to the conditions and end-users. While affordability and increased (inter-)national prioritization are essential, financial investment alone cannot solve the issue. A multifaceted approach is needed to enhance access to appropriate diagnostics in RLS. In addition, local regulatory infrastructures should be improved and possibly harmonized to advance the use of novel tests.
In this commentary, we propose key considerations for significantly improving global equitable access to bacteriology diagnostics. We start from the fact that despite advanced alternatives such as artificial intelligence-powered digital microscopy and microfluidics-based AST, culture-based detection and phenotypic AST remain the cornerstones of the bacteriology laboratory.
Read the full text here: Revisiting bacteriology diagnostics: how to make them globally available and accessible
Antibiotic stewardship
Surveillance bacteriology
